Stock Track | DexCom Plunges 5.89% After-Hours Despite Q4 Beat as 2026 Outlook Merely Reiterated

Stock Track

Feb 13

DexCom Inc. (DXCM) shares experienced a significant after-hours plunge of 5.89% following the release of its fourth-quarter financial results.

The medical device company reported quarterly adjusted earnings of $0.68 per share, beating the analyst consensus estimate of $0.65. Revenue for the quarter reached $1.26 billion, also surpassing expectations of $1.25 billion and marking an increase from the same period last year.

Despite the earnings and revenue beat, the stock sold off in post-market trading. A key factor appears to be the company's forward guidance. DexCom reiterated its full-year 2026 revenue outlook of $5.16 billion to $5.25 billion, which brackets the consensus estimate of $5.23 billion. The lack of a guidance raise following the quarterly beat may have disappointed investors who were anticipating more robust future projections.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1161501968"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161501968\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161501968?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-13 05:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161501968","market":"us","top_or_hot":-1,"title":"Stock Track | DexCom Plunges 5.89% After-Hours Despite Q4 Beat as 2026 Outlook Merely Reiterated","media":"Stock Track","content":"<p>DexCom Inc. (DXCM) shares experienced a significant after-hours plunge of 5.89% following the release of its fourth-quarter financial results.</p><p>The medical device company reported quarterly adjusted earnings of $0.68 per share, beating the analyst consensus estimate of $0.65. Revenue for the quarter reached $1.26 billion, also surpassing expectations of $1.25 billion and marking an increase from the same period last year.</p><p>Despite the earnings and revenue beat, the stock sold off in post-market trading. A key factor appears to be the company's forward guidance. DexCom reiterated its full-year 2026 revenue outlook of $5.16 billion to $5.25 billion, which brackets the consensus estimate of $5.23 billion. The lack of a guidance raise following the quarterly beat may have disappointed investors who were anticipating more robust future projections.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | DexCom Plunges 5.89% After-Hours Despite Q4 Beat as 2026 Outlook Merely Reiterated</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | DexCom Plunges 5.89% After-Hours Despite Q4 Beat as 2026 Outlook Merely Reiterated\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-13 05:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DexCom Inc. (DXCM) shares experienced a significant after-hours plunge of 5.89% following the release of its fourth-quarter financial results.</p><p>The medical device company reported quarterly adjusted earnings of $0.68 per share, beating the analyst consensus estimate of $0.65. Revenue for the quarter reached $1.26 billion, also surpassing expectations of $1.25 billion and marking an increase from the same period last year.</p><p>Despite the earnings and revenue beat, the stock sold off in post-market trading. A key factor appears to be the company's forward guidance. DexCom reiterated its full-year 2026 revenue outlook of $5.16 billion to $5.25 billion, which brackets the consensus estimate of $5.23 billion. The lack of a guidance raise following the quarterly beat may have disappointed investors who were anticipating more robust future projections.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DXCM","symbol_name":"德康医疗","start_time":0,"source_url":"","article_id":"1161501968","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161501968","pubTimestamp":1770933184,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"DexCom Inc. (DXCM) shares experienced a significant after-hours plunge of 5.89% following the release of its fourth-quarter financial results.The medical device company reported quarterly adjusted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DXCM":"德康医疗"},"translate_title":"股票追踪|尽管第四季度业绩好于预期，但DexCom盘后暴跌5.89%，仅重申了2026年前景","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DXCM":1},"content_text":"DexCom Inc. (DXCM) shares experienced a significant after-hours plunge of 5.89% following the release of its fourth-quarter financial results.The medical device company reported quarterly adjusted earnings of $0.68 per share, beating the analyst consensus estimate of $0.65. Revenue for the quarter reached $1.26 billion, also surpassing expectations of $1.25 billion and marking an increase from the same period last year.Despite the earnings and revenue beat, the stock sold off in post-market trading. A key factor appears to be the company's forward guidance. DexCom reiterated its full-year 2026 revenue outlook of $5.16 billion to $5.25 billion, which brackets the consensus estimate of $5.23 billion. The lack of a guidance raise following the quarterly beat may have disappointed investors who were anticipating more robust future projections.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}